84 related articles for article (PubMed ID: 22890637)
21. Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study.
Badjatia N; Fernandez L; Schmidt JM; Lee K; Claassen J; Connolly ES; Mayer SA
Neurosurgery; 2010 Apr; 66(4):696-700; discussion 700-1. PubMed ID: 20190667
[TBL] [Abstract][Full Text] [Related]
22. [Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].
Fukuda T; Mikoshiba M; Fukushima C; Nishi T; Nakajima S; Hasue M; Ikeda K; Sengoku Y; Ito H
No Shinkei Geka; 1996 Aug; 24(8):723-31. PubMed ID: 8741407
[TBL] [Abstract][Full Text] [Related]
23. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study.
Pearl JD; Macdonald RL
Acta Neurochir Suppl; 2008; 105():207-10. PubMed ID: 19066110
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.
Sanchez-Peña P; Nouet A; Clarençon F; Colonne C; Jean B; Le Jean L; Fonfrede M; Aout M; Vicaut E; Puybasset L
Crit Care Med; 2012 Feb; 40(2):594-602. PubMed ID: 21926584
[TBL] [Abstract][Full Text] [Related]
25. A Partial Least-Squares Analysis of Health-Related Quality-of-Life Outcomes After Aneurysmal Subarachnoid Hemorrhage.
Young JM; Morgan BR; Mišić B; Schweizer TA; Ibrahim GM; Macdonald RL
Neurosurgery; 2015 Dec; 77(6):908-15; discussion 915. PubMed ID: 26248048
[TBL] [Abstract][Full Text] [Related]
26. Clazosentan for patients with subarachnoid haemorrhage: lessons learned.
Wong GK; Poon WS
Lancet Neurol; 2011 Oct; 10(10):871; author reply 871-2. PubMed ID: 21939894
[No Abstract] [Full Text] [Related]
27. Predicting the overall management outcome in patients with a subarachnoid hemorrhage accompanied by a massive intracerebral or full-packed intraventricular hemorrhage: a 15-year retrospective study.
Nakagawa T; Suga S; Mayanagi K; Akaji K; Inamasu J; Kawase T;
Surg Neurol; 2005 Apr; 63(4):329-34; discussion 334-5. PubMed ID: 15808711
[TBL] [Abstract][Full Text] [Related]
28. The effect of intraventricular thrombolysis in combination with low-frequency head motion after severe subarachnoid hemorrhage: interim analysis of safety, clot clearance rate and delayed cerebral ischemia.
Eicker SO; Beseoglu K; Etminan N; Perrin J; Taskin A; Steiger HJ; Hänggi D
Acta Neurochir Suppl; 2012; 114():323-8. PubMed ID: 22327716
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
Springborg JB; Møller C; Gideon P; Jørgensen OS; Juhler M; Olsen NV
Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
[TBL] [Abstract][Full Text] [Related]
30. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
[TBL] [Abstract][Full Text] [Related]
31. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon?
Vergouwen MD; Vermeulen M; Roos YB
Stroke; 2009 Feb; 40(2):e39; author reply e40. PubMed ID: 19074477
[No Abstract] [Full Text] [Related]
32. Traumatic brain injury and subarachnoid hemorrhage: in vivo occult pathology demonstrated by magnetic resonance spectroscopy may not be "ischaemic". A primary study and review of the literature.
Macmillan CS; Wild JM; Wardlaw JM; Andrews PJ; Marshall I; Easton VJ
Acta Neurochir (Wien); 2002 Sep; 144(9):853-62; discussion 862. PubMed ID: 12376766
[TBL] [Abstract][Full Text] [Related]
33. Clazosentan (Actelion).
Uhlmann D
Curr Opin Investig Drugs; 2006 Mar; 7(3):272-81. PubMed ID: 16555688
[TBL] [Abstract][Full Text] [Related]
34. Cortisol and adrenocorticotropic hormone dynamics in the acute phase of subarachnoid haemorrhage.
Zetterling M; Engström BE; Hallberg L; Hillered L; Enblad P; Karlsson T; Ronne Engström E
Br J Neurosurg; 2011 Dec; 25(6):684-92. PubMed ID: 22115015
[TBL] [Abstract][Full Text] [Related]
35. Subarachnoid clot volume correlates with age, neurological grade, and blood pressure.
Rosen DS; Amidei C; Tolentino J; Reilly C; Macdonald RL
Neurosurgery; 2007 Feb; 60(2):259-66; discussion 266-7. PubMed ID: 17290176
[TBL] [Abstract][Full Text] [Related]
36. Fever after subarachnoid hemorrhage: risk factors and impact on outcome.
Fernandez A; Schmidt JM; Claassen J; Pavlicova M; Huddleston D; Kreiter KT; Ostapkovich ND; Kowalski RG; Parra A; Connolly ES; Mayer SA
Neurology; 2007 Mar; 68(13):1013-9. PubMed ID: 17314332
[TBL] [Abstract][Full Text] [Related]
37. Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage.
Naidech AM; Rosenberg NF; Maas MB; Bendok BR; Batjer HH; Nemeth AJ
Neurology; 2012 Mar; 78(11):811-5. PubMed ID: 22377811
[TBL] [Abstract][Full Text] [Related]
38. Effect of endothelin-receptor antagonists on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage remains unclear.
Vergouwen MD
Stroke; 2009 Dec; 40(12):e714; author reply e715-6. PubMed ID: 19875735
[No Abstract] [Full Text] [Related]
39. Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage.
Macdonald RL
Expert Opin Investig Drugs; 2008 Nov; 17(11):1761-7. PubMed ID: 18922111
[TBL] [Abstract][Full Text] [Related]
40. Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan.
Mutoh T; Aono H; Seto W; Kimoto T; Tochinai R; Moroi J; Ishikawa T
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
